Maravai Lifesciences Holdings MRVI Income Statement (2020-2026)

NASDAQ MRVI
$7.41 +0.04 (+0.47%)
As of: Sep 4, 2026 · 2:23 PM EDT
Reported Financials

Maravai Lifesciences Holdings Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Maravai Lifesciences Holdings reported revenue of $51.44M and net income of -$21.63M for the quarter ended Jun 2026, up 8.5% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
204.81M228.44M244.29M242.73M191.26M204.71M79.03M68.91M66.86M74.14M64.18M69.42M69.03M56.56M46.85M47.40M41.63M49.87M65.84M51.44M
Cost of RevenueCost of Rev
32.22M39.14M40.03M37.50M38.18M53.25M33.68M43.27M36.69M35.11M38.34M38.58M36.79M37.17M39.12M39.63M35.98M37.02M32.14M30.79M
Gross Profit
172.59M189.31M204.26M205.24M153.09M151.46M45.35M25.64M30.18M39.03M25.84M30.84M32.23M19.39M7.72M7.77M5.66M12.84M33.70M20.65M
Operating items
Research & DevelopmentR&D
1.95M9.18M3.69M4.27M5.39M5.01M4.14M4.19M4.35M4.59M5.03M4.92M4.70M4.56M4.89M4.88M3.84M3.79M3.89M3.70M
Selling, General & AdministrativeSG&A
26.51M25.58M33.20M28.06M30.80M37.20M38.67M35.38M38.86M38.48M40.88M40.56M39.09M41.24M39.56M38.72M35.40M31.58M29.09M32.07M
Restructuring CostsRestructuring
6.47M-1.21M-0.00M-0.00M0.01M7.39M10.44M2.88M-0.03M
Other Operating ExpensesOther Opex
11.25M40.03M29.70M33.68M40.96M39.07M-116.99M38.34M37.39M154.06M11.28M12.44M30.45M0.06M25.82M
Operating ExpensesOpex
49.43M73.90M76.93M62.03M74.36M95.47M76.49M80.53M82.28M-67.45M83.04M82.86M197.85M57.09M56.89M74.05M46.69M71.64M35.86M35.74M
Operating IncomeOp. Inc
155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M-58.80M-2.16M-15.09M
EBIT
155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M-58.80M-2.16M-15.09M
Non-operating items
Non Operating Interest Expenses
7.68M7.02M2.66M4.43M3.14M10.18M11.83M7.02M11.64M15.40M10.86M11.94M13.63M11.26M6.78M6.82M6.84M6.55M5.75M4.81M
Interest & Investment IncomeInt & Inv Inc
2.34M6.04M6.79M7.43M7.46M7.21M7.09M7.07M6.04M3.23M3.03M2.80M2.38M1.87M1.16M
Other Non Operating IncomeOther Non Op Inc.
0.08M0.20M-0.21M-1.27M-0.00M0.91M0.17M-1.62M0.07M0.05M0.11M-2.56M0.07M-0.80M0.02M-4.06M-0.07M-0.04M-0.49M-3.01M
Net income details
EBT
151.02M144.69M166.84M174.99M113.76M95.88M-4.52M-13.36M-20.56M656.19M-22.41M-20.86M-172.14M-46.07M-52.69M-74.12M-45.15M-63.01M-6.53M-21.80M
Tax ProvisionsTaxes
18.84M17.58M19.98M18.27M14.11M8.45M-3.17M-1.42M-5.46M766.17M0.27M-2.44M0.31M-0.01M0.16M-4.29M-0.09M0.01M-0.15M-0.17M
Profit After TaxPAT
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Income from Non-Controlling InterestsInc. Minority
78.22M71.28M80.00M85.48M55.18M49.80M-1.28M-5.40M-8.64M-4.02M-10.60M-8.63M-75.38M-20.16M-22.91M-30.25M-19.50M-27.33M-2.64M-9.21M
Income from Continuing OperationsIncome (Continuing)
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Consolidated Net IncomeConsol Net Inc.
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Income towards Parent CompanyParent Net Inc
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Net Income towards Common StockholdersNet Income
132.18M127.11M146.86M156.72M99.65M87.43M-1.35M-11.94M-15.10M-109.98M-22.68M-18.42M-172.46M-46.07M-52.85M-69.84M-45.06M-63.02M-6.38M-21.63M
Additional items
EPS (Basic)
1.121.111.121.190.760.66-0.01-0.09-0.11-0.83-0.17-0.14-1.22-0.33-0.37-0.48-0.31-0.44-0.04-0.15
EPS (Diluted)
0.510.490.580.610.760.34-0.01-0.09-0.11-0.83-0.17-0.14-1.22-0.33-0.37-0.48-0.31-0.44-0.04-0.15
Shares Outstanding
118.43M114.79M131.49M131.52M131.54M131.54M131.74M131.86M131.93M131.92M132.33M135.84M141.56M137.91M143.43M144.24M144.68M144.36M146.43M148.00M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
258.03M257.80M255.29M255.36M131.65M255.32M131.74M131.86M131.93M131.92M132.33M135.84M141.56M137.91M143.43M144.24M144.68M144.36M146.43M148.00M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
257.70M255.16M255.21M255.21M255.21M255.36M250.98M251.00M251.04M251.32M251.75M252.24M252.27M254.34M254.66M255.30M255.40M256.01M258.18M259.67M
EBITDA
155.38M154.54M167.37M180.70M116.90M109.25M2.53M-11.61M-15.42M-7.15M-18.86M-13.44M-165.61M-37.70M-49.16M-66.28M-41.03M-58.80M-2.16M-15.09M
Interest ExpensesInt Expense
7.68M7.02M2.66M4.43M3.14M10.18M11.83M7.02M11.64M15.40M10.86M11.94M13.63M11.26M6.78M6.82M6.84M6.55M5.75M4.81M
Tax Rate
12.48%12.15%11.98%10.44%12.40%8.81%70.20%10.63%26.56%116.76%-1.21%11.68%-0.18%0.02%-0.31%5.78%0.20%-0.01%2.31%0.78%